Skip to main content
Terug
Watch Compare

FENNEC PHARMACEUTICALS INC.

Datakwaliteit: 100%
FENC
Nasdaq Manufacturing Chemicals
€ 6,42
▼ € 0,07 (-1,08%)
Marktkapitalisatie: 221,33 M
Prijs
€ 6,42
Marktkapitalisatie
221,33 M
Dagbereik
€ 6,25 — € 6,47
52-Weeksbereik
€ 4,87 — € 9,92
Volume
44.526
Openen € 6,45
50D / 200D Gem.
€ 7,68
16,40% below
50D / 200D Gem.
€ 8,18
21,47% below

Quick Summary

Belangrijkste Punten

Revenue grew 302,55% annually over 5 years — strong growth
Negative free cash flow of -12,47 M
Revenue growth is decelerating — 1Y growth trails 5Y average by 308,64%

Groei

Revenue Growth (5Y)
302,55%
Boven sectorgemiddelde (1,82%)
Revenue (1Y)-6,09%
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Kwaliteit

Return on Equity
N/A
ROIC-13,08%
Net Margin-21,82%
Op. Margin-14,07%

Veiligheid

Debt / Equity
N/A
Current Ratio4,69
Interest Coverage-3,02

Waardering

PE (TTM)
-22,72
Onder sectorgemiddelde (-1,48)
P/B RatioN/A
EV/EBITDAN/A
Dividend YieldN/A

Koershistorie

Financiële Trends

Sectorvergelijking

vs Manufacturing sector mediaan (1364 peers)
Metriek Aandeel Sector Mediaan
P/E -22,7 -1,5
P/B — 1,6
ROE % — -53,4
Net Margin % -21,8 -41,5
Rev Growth 5Y % 302,6 1,8
D/E — 0,3

All Fundamental Metrics
Growth
Revenue Growth (1Y) -6,09% Revenue Growth (3Y) 44,93%
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) 302,55% Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 44,64 M Net Income (TTM) -9,74 M
ROE N/A ROA -20,70%
Gross Margin N/A Operating Margin -14,07%
Net Margin -21,82% Free Cash Flow (TTM) -12,47 M
ROIC -13,08% FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 4,69
Interest Coverage -3,02 Asset Turnover 0,95
Working Capital 36,25 M Tangible Book Value -4,49 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -22,72 Forward P/E N/A
P/B Ratio N/A P/S Ratio 4,96
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -5,64%
Market Cap 221,33 M Enterprise Value 218,76 M
Per Share
EPS (Diluted TTM) -0,34 Revenue / Share 1,29
FCF / Share -0,36 OCF / Share -0,36
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue N/A FCF Conversion 128,05%
SBC-Adj. FCF -17,91 M Growth Momentum -308,64

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 44,64 M 47,54 M 21,25 M — 170.000,0
Net Income -9,74 M -436.000,0 -16,05 M -23,71 M -17,35 M
EPS (Diluted) -0,34 -0,02 -0,60 -0,90 -0,67
Gross Profit — — 19,99 M 1,45 M —
Operating Income -6,28 M 2,57 M -12,77 M -22,59 M -17,22 M
EBITDA — — — — —
R&D Expenses 250.000,0 307.000,0 56.000,0 3,53 M 4,98 M
SG&A Expenses — — — — —
D&A — — — — —
Interest Expense 2,08 M 4,07 M 441.000,0 — —
Income Tax 106.000,0 365.000,0 — 0,0 0,0

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 70,55 M 44,95 M 26,86 M 26,94 M 22,41 M
Total Liabilities 35,08 M 50,82 M 38,49 M 29,51 M 6,64 M
Shareholders' Equity 35,47 M -5,87 M -11,62 M -2,57 M 15,77 M
Total Debt — 19,34 M 30,93 M 24,90 M —
Cash & Equivalents 36,79 M 26,63 M 13,27 M 23,77 M 21,10 M
Current Assets 67,04 M 44,12 M 26,86 M 26,73 M 22,39 M
Current Liabilities 10,52 M 6,92 M 7,55 M 4,61 M 1,65 M